References

ACS (American Cancer Society). 1995. Breast Cancer Facts and Figures 1996. Atlanta: ACS.

ACS. 1996a. Oral and written comments presented to the Committee to Review the Department of Defense's Breast Cancer Research Program. Washington, D.C.: ACS, September 5.

ACS. 1996b. Research Program Report 1995. Atlanta: ACS.

ACS. 1997. Report to the Board of Directors from the Workshop on Guidelines for Breast Cancer Detection. Atlanta: ACS.


Barofsky, I., and P.H. Sugarbaker. 1990. Cancer. Pp. 419-439 in Quality of Life Assessments in Clinical Trials, Spilker, B., ed. New York: Raven Press.

Berns, E.M., J.A. Foekens, I.L. van Staveren, et al. 1995. Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment. Gene 159:11-18.

Brower, V. 1997. Lawyers, physicians seek genomic rules. Nature Biotechnol . 15:10.


CBCRP (California Breast Cancer Research Program). 1997. BCRP's Home Page. [WWW document]. URL http://www.ucop.edu/srphome/bcrp

CDC (Centers for Disease Control and Prevention). 1997. World Wide Web site. URL http://www.cdc.gov

Colditz, G.A., W.C. Willett, D.J. Hunter, et al. 1993. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. J. Am. Med. Assoc. 270:338-343.

Committee on Appropriations, U.S. House of Representatives. 1993. H. Rpt. 103-339, 11/09/93, pp. 110-111.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 107
A Review of the Department of Defense's Program for Breast Cancer Research References ACS (American Cancer Society). 1995. Breast Cancer Facts and Figures 1996. Atlanta: ACS. ACS. 1996a. Oral and written comments presented to the Committee to Review the Department of Defense's Breast Cancer Research Program. Washington, D.C.: ACS, September 5. ACS. 1996b. Research Program Report 1995. Atlanta: ACS. ACS. 1997. Report to the Board of Directors from the Workshop on Guidelines for Breast Cancer Detection. Atlanta: ACS. Barofsky, I., and P.H. Sugarbaker. 1990. Cancer. Pp. 419-439 in Quality of Life Assessments in Clinical Trials, Spilker, B., ed. New York: Raven Press. Berns, E.M., J.A. Foekens, I.L. van Staveren, et al. 1995. Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment. Gene 159:11-18. Brower, V. 1997. Lawyers, physicians seek genomic rules. Nature Biotechnol . 15:10. CBCRP (California Breast Cancer Research Program). 1997. BCRP's Home Page. [WWW document]. URL http://www.ucop.edu/srphome/bcrp CDC (Centers for Disease Control and Prevention). 1997. World Wide Web site. URL http://www.cdc.gov Colditz, G.A., W.C. Willett, D.J. Hunter, et al. 1993. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. J. Am. Med. Assoc. 270:338-343. Committee on Appropriations, U.S. House of Representatives. 1993. H. Rpt. 103-339, 11/09/93, pp. 110-111.

OCR for page 107
A Review of the Department of Defense's Program for Breast Cancer Research Committee on Appropriations, U.S. House of Representatives. 1994a. H. Rpt. 103-562, 06/27/94, p. 273. Committee on Appropriations, U.S. House of Representatives. 1994b. H. Rpt. 103-747, 09/26/94, p. 149. CTI (Critical Technologies Institute)/RAND datasearch. 1996. DHHS (U.S. Department of Health and Human Services). 1996a. New Frontiers in Breast Cancer Imaging and Early Detection. Washington, D.C.: U.S. Public Health Service, Office on Women's Health. DHHS. 1996b. President Clinton Announces National Action Plan on Breast Cancer Internet Web Site. [WWW document]. URL http://www.hhs.gov/news/press/1996pres/961028a.html (accessed November 8, 1996). Early Breast Cancer Trialists' Collaborative Group. 1992. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339:1-15, 71-85. Elwood, J.M., B. Cox, and A.K. Richardson. 1993. The effectiveness of breast cancer screening by mammography in younger women. Online J. Curr. Clin. Trials Document No. 32. Hall, F.M. 1986. Screening mammography-potential problems on the horizon. N. Engl. J. Med. 314:53-55. Harris, J.R., M.E. Lippman, U. Veronesi, and W. Willett. 1992a. Breast Cancer (Part 1). N. Engl. J. Med. 327:319-328. Harris, J.R., M.E. Lippman, U. Veronesi, and W. Willett. 1992b. Breast Cancer (Part 3) N. Engl. J. Med. 327:473-480. Horton, J.A., M.C. Romans, and D.F. Cruess. 1992. Mammography Attitudes and Usage Study, 1992. Women's Health Issues 2:180-188. Hryniuk, W., and M.N. Levine. 1986. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. J. Clin. Oncol. 4:1162-1170. IOM (Institute of Medicine). 1993. Strategies for Managing the Breast Cancer Research Program: A Report to the U.S. Army Medical Research and Development Command. Washington, D.C.: National Academy Press. IOM. 1995. Recommendations for Research on the Health of Military Women. Washington, D.C.: National Academy Press. IOM. 1996. Military Researchers Interested in Women's Health Issues. Directory. Washington, D.C.: National Academy Press. Kelsey, J.L., and M.D. Gammon. 1990. Epidemiology of Breast Cancer. Epidemiol. Rev. 12:228-240. Kerlikowske, K., D. Grady, J. Barclay, E.A. Sickles, and V. Ernster. 1996. Effect of age, breast density, and family history on the sensitivity of first screening mammography. J. Am. Med. Assoc. 276:33-38.

OCR for page 107
A Review of the Department of Defense's Program for Breast Cancer Research Susan G. Komen Foundation. 1996. Oral and written comments presented to the Committee to Review the Department of Defense's Breast Cancer Research Program. Washington, D.C. Kosary, C.L., L.A. Gloeckler, B.A. Miller, et al. 1996. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. (NIH Pub. No. 96-2789). Bethesda, Md.: National Cancer Institute. Li, L., X. Li, U. Francke, and S.N. Cohen. 1997. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88:143-154. Love, S.M., with K. Lindsey. 1995. Dr. Susan Love's Breast Book. Reading, Pa.: Addison-Wesley. Malkin, D., F.P. Li, L.C. Strong, et al. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238. McDowell, I., and C. Newell. 1987. Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press. Miki, Y., J. Swensen, D. Shattuck-Eidens, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71. Miller, B.A., E.J. Feuer, and B.F. Hankey. 1993. Recent incidence trends for breast cancer in women and the relevance of early detection: An update. CA Cancer J. Clin. 43:27-41. Miller, B.A., L.N. Kolonel, L. Bernstein, et al. 1996. Racial/ethnic patterns of cancer in the United States 1988-1992. (NIH Pub. No. 96-4104). Bethesda, Md.: National Cancer Institute. NAPBC (National Action Plan on Breast Cancer). 1996. Grant Information . [WWW document]. http://www.napbc.org/napbc/grantinf.html (accessed November 8, 1996). NCI. 1996. Written statement in response to questions from the Committee to Review the Department of Defense's Breast Cancer Research Program. August 20, 1996. NCI. 1997a. Cancer Net Mail Service. [WWW document]. URL http://cancernet.icicc.nci.nih.gov NCI. 1997b. Cancer Information Service (1 800 4 Cancer). NIH (National Institutes of Health). 1997. National Institutes of Health Consensus Development Conference Statement. Breast Cancer Screening for Women Ages 40-49. Bethesda, Md.: NIH. PhRMA (Pharmaceutical Research and Manufacturers of America). 1995. New Medicines in Development for Cancer. Washington, D.C.: PhRMA. Pisani, P. 1992. Breast cancer: Geographic variation and risk factors. J. Environ. Pathol. Toxicol. Oncol. 11:313-316.

OCR for page 107
A Review of the Department of Defense's Program for Breast Cancer Research Romans, M.C. 1992. Report from The Jacobs Institute--American Cancer Society workshop on mammography screening and primary care providers: Current issues. Women's Health Issues 2:169-172. SAIC (Science Applications International Corporation). 1996. Orientation Handbook for New Integration Panel Members. A Programmatic Review Primer. Fort Detrick, Md.: SAIC, June 13. Savitsky, K., A. Bar-Shira, S. Gilad, et al. 1995. A single ataxia telangiectasia gene with a product similar to P1-3 kinase. Science 268: 1749-1753. Serova, O., M. Montagna, D. Torchard, et al. 1996. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am. J. Hum. Genet. 58:42-51. Silvestrini, R., S. Veneroni, M.G. Daidone, et al. 1994. The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J. Natl. Cancer Inst. 86:499-504. Smith, R.A., B.L. Black, G.W. Price, et al. 1992. Workshop IV: Legal aspects, legislative effect, cost-effectiveness, and barriers to breast cancer screening. Cancer 69(Suppl.):2005-2007. Stewart, A.L., and J.E. Ware. 1992. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, N.C.: Duke University Press. Stewart, T.H.M., M.W. Retsky, S.C.J. Tsai, and S. Verma. 1994. Dose response in the treatment of breast cancer. Lancet 343:402-404. Strax, P. 1990. Detection of breast cancer. Cancer 66(Suppl.):1336-1340. UIS (United Information Systems). 1996. Procedural Manual for Executive Secretaries. Bethesda, Md.: UIS. USAMRDC (U.S. Army Medical Research and Development Command). 1993. Broad Agency Announcement for Breast Cancer Research. Fort Detrick, Md.: USAMRDC, September 15. USAMRMC (U.S. Army Medical Research and Materiel Command). 1995a. Abstracts: Breast Cancer Research Program FY 92, 93 and 94. Fort Detrick, Md.: USAMRMC, October 4. USAMRMC. 1995b. Broad Agency Announcement for Breast Cancer Research . Fort Detrick, Md.: USAMRMC, June 1. USAMRMC. 1995c. Supplement to the Broad Agency Announcement for Breast Cancer Research for the Breast Cancer Center Program. Fort Detrick, Md.: USAMRMC, June 15. USAMRMC. 1995d. U.S. Army Breast Cancer Research Program: 1993-1994 Award List and Glossary of Terms. Fort Detrick, Md.: USAMRMC, March 17.

OCR for page 107
A Review of the Department of Defense's Program for Breast Cancer Research USAMRMC. 1996a. Broad Agency Announcement for Department of Defense Breast Cancer Research Program. Fort Detrick, Md.: USAMRMC, April 15. USAMRMC. 1996b. Department of Defense Breast Cancer Research Program: 1995 Abstract Book. Fort Detrick, Md.: USAMRMC. USAMRMC. 1996c. Written and oral presentations to the Committee to Review the Department of Defense's Breast Cancer Research Program. Washington, D.C.: USAMRMC, July 8 and September 4. USAMRMC. 1996d. U.S. Army Breast Cancer Research Program: 1995 Award List and Glossary of Terms. Fort Detrick, Md.: USAMRMC, October 1. USAMRMC. 1997. Oral presentations to the Committee to Review the Department of Defense's Breast Cancer Research Program. Washington, D.C.: USAMRMC, January 13-14. Wadman, M. 1996. Breast cancer policy comes under fire. Nature 383:113. Wood, W.C., D.R. Budman, A.H. Korzun, et al. 1994. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N. Engl. J. Med. 330:1253-1259. Wooster R., G. Bignell, J. Lancaster, et al. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792. Ziegler, R.G., R.N. Hoover, M.C. Pike, et al. 1993. Migration patterns and breast cancer risk in Asian-American women . J. Natl. Cancer Inst. 85:1819-1827. Zukerberg, L.R., W.-I. Yang, M. Gadd, et al. 1995. Cyclin D1 (PRAD1) protein expression in breast cancer: Approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod. Pathol. 8:560-567.

OCR for page 107
A Review of the Department of Defense's Program for Breast Cancer Research This page in the original is blank.